ATI LPN
ATI PN Comprehensive Predictor 2020
1. Which nursing action is best when managing a client with severe anxiety?
- A. Maintain a calm manner
- B. Help the client identify thoughts prior to the anxiety
- C. Administer anti-anxiety medication
- D. Initiate seclusion if anxiety escalates
Correct answer: A
Rationale: The correct answer is to maintain a calm manner. When managing a client with severe anxiety, the nurse's calm presence can help the client feel more secure and reduce their anxiety levels. It is essential to create a safe and supportive environment. Helping the client identify thoughts prior to anxiety (choice B) may be beneficial in cognitive-behavioral interventions but may not be the initial best action for severe anxiety. Administering anti-anxiety medication (choice C) should be done by a healthcare provider's order and is not the first-line intervention for managing severe anxiety. Initiating seclusion (choice D) should only be considered as a last resort if the client is at risk of harm to themselves or others, as it can further escalate anxiety and should not be the initial action.
2. A nurse is caring for a client who has diabetes mellitus and is receiving insulin. Which of the following findings should the nurse report to the provider?
- A. A fasting blood glucose of 90 mg/dL
- B. A blood glucose level of 200 mg/dL
- C. A hemoglobin A1c of 6%
- D. A fasting blood glucose of 100 mg/dL
Correct answer: B
Rationale: The correct answer is B. A blood glucose level of 200 mg/dL indicates hyperglycemia, which may necessitate insulin adjustment to better control the client's blood sugar levels. A fasting blood glucose of 90 mg/dL (choice A) is within the normal range, a hemoglobin A1c of 6% (choice C) is indicative of good long-term blood sugar control, and a fasting blood glucose of 100 mg/dL (choice D) is also within the normal range. Therefore, these findings do not require immediate reporting to the provider.
3. What are the nursing interventions for a patient receiving anticoagulant therapy?
- A. Monitor INR levels and check for bleeding
- B. Administer antiplatelet therapy
- C. Check for signs of DVT and provide anticoagulation
- D. Administer aspirin and monitor for bleeding
Correct answer: A
Rationale: The correct nursing intervention for a patient receiving anticoagulant therapy is to monitor INR levels and check for signs of bleeding. Monitoring the INR levels helps assess the effectiveness and safety of anticoagulant therapy, while checking for bleeding is essential due to the increased risk associated with anticoagulants. Choice B is incorrect as antiplatelet therapy is not the standard treatment for patients on anticoagulant therapy. Choice C is incorrect as providing additional anticoagulation is not a direct nursing intervention in this scenario. Choice D is incorrect because administering aspirin, an antiplatelet medication, along with anticoagulants can increase the risk of bleeding and is generally avoided.
4. A nurse is assessing a client who is prescribed spironolactone. Which of the following laboratory values should the nurse monitor for this client?
- A. Total bilirubin.
- B. Urine ketones.
- C. Serum potassium.
- D. Platelet count.
Correct answer: C
Rationale: The correct answer is C: Serum potassium. Spironolactone is a potassium-sparing diuretic, meaning it helps the body retain potassium. Therefore, the nurse should monitor the client's serum potassium levels to prevent hyperkalemia, which can be a potential side effect of spironolactone. Monitoring total bilirubin levels (A) is not specifically required for clients taking spironolactone. Urine ketones (B) are not directly influenced by spironolactone use. Platelet count (D) is not typically monitored in clients taking spironolactone.
5. A client scheduled to begin chemotherapy is discussing alopecia with a nurse. Which of the following statements should the nurse make?
- A. Avoid washing your hair during treatment
- B. Your oncologist might prescribe a cold cap during treatment to reduce hair loss
- C. You'll need to apply sunscreen to the scalp
- D. You'll likely experience regrowth of hair within 6 months after treatment ends
Correct answer: B
Rationale: The correct answer is B. The nurse should inform the client that their oncologist might prescribe a cold cap during treatment to reduce chemotherapy-induced hair loss by cooling the scalp. Choice A is incorrect as washing the hair during treatment is generally recommended. Choice C is incorrect as sunscreen is not typically needed for the scalp in this context. Choice D is incorrect as regrowth of hair can vary among individuals and is not guaranteed within a specific timeframe.
Similar Questions
Access More Features
ATI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access